LOREEV XR

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 52427-667
  • Package NDC 52427-667-30
  • Application number NDA214826
  • SPL ID fa403ae4-25fa-9fb8-1596-342d4560c6da
  • SPL set ID 227734c1-bf01-9607-73ea-5a1f38a89bd9
  • UNII O26FZP769L
  • RxCUI 2569564
  • RxCUI 2569571
  • RxCUI 2569573
  • RxCUI 2569575
  • RxCUI 2569577
  • RxCUI 2569580
  • RxCUI 2594600
  • RxCUI 2594603

What the source publishes

Labeler
Almatica Pharma LLC
Active ingredients
lorazepam
Form
CAPSULE, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:52427-667_fa403ae4-25fa-9fb8-1596-342d4560c6da
{
  "name": "LOREEV XR",
  "splId": "fa403ae4-25fa-9fb8-1596-342d4560c6da",
  "labels": [
    {
      "setId": "227734c1-bf01-9607-73ea-5a1f38a89bd9",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=227734c1-bf01-9607-73ea-5a1f38a89bd9",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=227734c1-bf01-9607-73ea-5a1f38a89bd9"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Almatica Pharma LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52427-667-30)",
      "package_ndc": "52427-667-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210924"
    }
  ],
  "productId": "52427-667_fa403ae4-25fa-9fb8-1596-342d4560c6da",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE, EXTENDED RELEASE",
  "productNdc": "52427-667",
  "deaSchedule": "CIV",
  "genericName": "lorazepam",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LORAZEPAM",
      "strength": "3 mg/1"
    }
  ],
  "applicationNumber": "NDA214826",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210831",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175694",
      "M0002356"
    ],
    "upc": [
      "0352427663307",
      "0352427658303",
      "0352427667305",
      "0352427661303"
    ],
    "unii": [
      "O26FZP769L"
    ],
    "rxcui": [
      "2569564",
      "2569571",
      "2569573",
      "2569575",
      "2569577",
      "2569580",
      "2594600",
      "2594603"
    ],
    "spl_set_id": [
      "227734c1-bf01-9607-73ea-5a1f38a89bd9"
    ],
    "pharm_class_cs": [
      "Benzodiazepines [CS]"
    ],
    "pharm_class_epc": [
      "Benzodiazepine [EPC]"
    ],
    "manufacturer_name": [
      "Almatica Pharma LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:52427-667_fa403ae4-25fa-9fb8-1596-342d4560c6da"